PubRank

Ping-I Hsu

Author PubWeight™ 83.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol 2009 2.15
2 Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005 2.03
3 Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 2008 1.95
4 Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004 1.81
5 Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest Endosc 2006 1.75
6 The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 2005 1.63
7 A new look at anti-Helicobacter pylori therapy. World J Gastroenterol 2011 1.59
8 Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation. Scand J Gastroenterol 2008 1.55
9 Comparison of hemostatic efficacy for argon plasma coagulation and distilled water injection in treating high-risk bleeding ulcers. J Clin Gastroenterol 2009 1.52
10 Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. J Chin Med Assoc 2008 1.46
11 Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma. J Chin Med Assoc 2004 1.46
12 Emergency endoscopic variceal ligation versus somatostatin for acute esophageal variceal bleeding. J Chin Med Assoc 2006 1.41
13 Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterol 2011 1.29
14 Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrob Chemother 2009 1.21
15 Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg 2009 1.20
16 Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol 2005 1.17
17 The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010 1.12
18 Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect Immun 2007 1.10
19 Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005 1.09
20 Randomized controlled trial of monthly versus biweekly endoscopic variceal ligation for the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol 2014 1.05
21 Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 2010 1.02
22 One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol 2002 1.02
23 A prospective, randomized trial of endoscopic hemoclip placement and distilled water injection for treatment of high-risk bleeding ulcers. Gastrointest Endosc 2003 0.99
24 Comparison of noninvasive diagnostic tests for Helicobacter pylori infection. Med Princ Pract 2008 0.97
25 Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. J Gastroenterol Hepatol 2012 0.97
26 Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial. J Antimicrob Chemother 2012 0.95
27 Erosive esophagitis in asymptomatic subjects: risk factors. Dig Dis Sci 2009 0.95
28 Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter 2012 0.95
29 Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003 0.93
30 Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies. Medicine (Baltimore) 2011 0.93
31 Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers. World J Gastroenterol 2005 0.92
32 The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest Endosc 2004 0.92
33 Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002 0.92
34 Do patients with recurrent choledocholithiasis after endoscopic sphincterotomy benefit from regular follow-up? Gastrointest Endosc 2002 0.92
35 Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol 2009 0.90
36 Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma. J Chin Med Assoc 2003 0.87
37 Linear echoendoscope-guided ERCP for the diagnosis of occult common bile duct stones. BMC Gastroenterol 2013 0.86
38 Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World J Gastroenterol 2011 0.86
39 The clinical and cholangiographic picture of hepatic clonorchiasis. J Clin Gastroenterol 2002 0.85
40 Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection. Helicobacter 2007 0.85
41 Prevalence and risk factors of erosive esophagitis in Taiwan. J Chin Med Assoc 2012 0.84
42 Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy. Helicobacter 2010 0.84
43 Acute pancreatitis-associated acute gastrointestinal mucosal lesions: incidence, characteristics, and clinical significance. J Clin Gastroenterol 2007 0.84
44 Establishment of red fluorescent protein-tagged HeLa tumor metastasis models: determination of DsRed2 insertion effects and comparison of metastatic patterns after subcutaneous, intraperitoneal, or intravenous injection. Clin Exp Metastasis 2003 0.84
45 Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. World J Gastroenterol 2004 0.83
46 Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract 2013 0.83
47 Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy. World J Gastroenterol 2005 0.82
48 Adenomyoma of the jejunum --- a rare cause of gastrointestinal bleeding. J Chin Med Assoc 2008 0.82
49 Endoscopic banding ligation can effectively resect hyperplastic polyps of stomach. World J Gastroenterol 2003 0.82
50 Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget 2014 0.82
51 Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Helicobacter 2014 0.82
52 The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett's Esophagus in Taiwan. Gastroenterol Res Pract 2013 0.82
53 Gastric juice acidity in upper gastrointestinal diseases. World J Gastroenterol 2010 0.81
54 Factors related to incomplete flexible sigmoidoscopy among adult Chinese in Taiwan. J Chin Med Assoc 2007 0.81
55 A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol 2009 0.81
56 Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. Am J Gastroenterol 2012 0.80
57 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan. Gastroenterol Res Pract 2012 0.80
58 Real-world application of the roadmap model in chronic hepatitis B patients with telbivudine therapy. Clin Ther 2013 0.80
59 Diffuse malignant peritoneal mesothelioma. Kaohsiung J Med Sci 2013 0.79
60 Observation of peptide differences between cancer and control in gastric juice. Proteomics Clin Appl 2008 0.79
61 The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria. Gastroenterol Res Pract 2013 0.79
62 Gastrointestinal mucosal lesions in patients with acute pancreatitis. Zhonghua Yi Xue Za Zhi (Taipei) 2002 0.79
63 High-dose bisacodyl plus water lavage compared with oral sodium phosphate as bowel preparation for outpatient colonoscopy. J Chin Med Assoc 2009 0.79
64 The relationship between gallbladder status and recurrent biliary complications in patients with choledocholithiasis following endoscopic treatment. J Chin Med Assoc 2012 0.79
65 Prevalence of gastroesophageal reflux disease in a general population in Taiwan. J Gastroenterol Hepatol 2011 0.79
66 A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. Medicine (Baltimore) 2016 0.78
67 Clip-assisted endoscopic method for placement of a nasoenteric feeding tube into the distal duodenum. J Formos Med Assoc 2003 0.78
68 Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis. J Dig Dis 2012 0.78
69 Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy. J Formos Med Assoc 2012 0.78
70 Capsule 13C-urea breath test for the diagnosis of Helicobacter pylori infection. World J Gastroenterol 2005 0.78
71 Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding. J Chin Med Assoc 2004 0.77
72 Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma. World J Gastroenterol 2006 0.77
73 Compartment theory in Helicobacter pylori-associated gastric carcinogenesis. Anticancer Res 2003 0.77
74 Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori. Am J Med Sci 2011 0.77
75 Clinical application of clip-assisted endoscopic method for nasoenteric feeding in patients with gastroparesis and gastroesophageal wounds. World J Gastroenterol 2005 0.77
76 Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study. Antivir Ther 2014 0.76
77 Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. Helicobacter 2014 0.76
78 Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. BMC Gastroenterol 2012 0.76
79 Early entecavir treatment for chronic hepatitis B with severe acute exacerbation. Antimicrob Agents Chemother 2014 0.76
80 Nodular regenerative hyperplasia of the liver. J Chin Med Assoc 2008 0.76
81 Endoscopic treatment in a patient with obstructive jaundice caused by pancreatic pseudocyst. J Chin Med Assoc 2003 0.76
82 Risk factors of mortality after surgical treatment of intestinal obstruction in patients having prior laparotomy for non-malignancy. J Chin Med Assoc 2003 0.75
83 Influence of juxtapapillary diverticulum on hepatic clearance in patients after endoscopic sphincterotomy. J Gastroenterol Hepatol 2005 0.75
84 Application of serology in the diagnosis of Helicobacter pylori infection in patients with atrophic gastritis. J Chin Med Assoc 2010 0.75
85 Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005 0.75
86 Gallbladder cancer manifesting as recurrent common bile duct stone and duodenal ulcer bleeding. J Chin Med Assoc 2009 0.75
87 Is epinephrine the best solution for large-volume endoscopic injection of peptic ulcer bleeding? Gastrointest Endosc 2005 0.75
88 Improvement of Short-Term Outcomes for High-Risk Bleeding Peptic Ulcers With Addition of Argon Plasma Coagulation Following Endoscopic Injection Therapy: A Randomized Controlled Trial. Medicine (Baltimore) 2015 0.75
89 Impact of food on hepatic clearance of patients after endoscopic sphincterotomy. J Chin Med Assoc 2009 0.75
90 Primary aortoduodenal fistula caused by tuberculous aortitis presenting as recurrent massive gastrointestinal bleeding. J Formos Med Assoc 2008 0.75
91 Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients. J Chin Med Assoc 2006 0.75
92 Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens. Kaohsiung J Med Sci 2013 0.75
93 Intestinal obstruction in patients with previous laparotomy for non-malignancy. J Chin Med Assoc 2005 0.75
94 Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin. Curr Pharm Des 2015 0.75
95 Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection. J Chin Med Assoc 2004 0.75
96 Does a fatty meal improve hepatic clearance in patients after endoscopic sphincterotomy? J Gastroenterol Hepatol 2002 0.75